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na, and thromboembolic complications or as an adjunct
for therapy of ventricular arrhythmias. The original
description of the procedure as applied to discrete dys-
kinetic aneurysms included excision of the thin-walled
sack, leaving behind a rim of scar to facilitate closure,
which was accomplished in a linear fashion.1
Modifications of the original technique have been advo-
cated that include the purse-string technique of Jatene,2
the endoventricular circuloplasty of Dor and col-
F or many years, left ventricular (LV) aneurysm resec-tion has been recommended in patients with coro-
nary artery disease as a treatment for heart failure, angi-
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leagues,3 and the endoaneurysmorrhaphy technique
originally described by Cooley.4 Controversy has exist-
ed over whether patients with less discrete akinetic
aneurysms will benefit from wall excision and repair.5,6
Since 1983, we have used a modified linear closure
technique for aneurysm repair in patients with both
akinetic and dyskinetic aneurysms.7 This repair tech-
nique has been combined with patch septoplasty in
selected cases. This report updates our experience
and highlights long-term results achieved with this
simple, reproducible technique. In this series we have
used preoperative and postoperative multiple gated
acquisition (MUGA) and echocardiographic data to
provide objective evidence of improved LV and
mitral valve function.
Material and methods
Patient population. Between 1983 and 1997, 196 consec-
utive patients underwent LV aneurysm repair by a single staff
surgeon (L.M.). In all but 3 cases (excluded from this analy-
sis), tailored excision of scar was followed by a modified lin-
ear closure.
Patients were selected for operation. Gross chamber dilata-
tion was not a contraindication so long as contractile function
was preserved in some portion of the ventricle. Patients with
severe right ventricular dysfunction or severe pulmonary
hypertension and those with diffuse disease in all coronary
distributions were considered to have inoperable disease.
Associated severe mitral regurgitation (MR) was a relative
contraindication.
The 193 patients ranged in age from 22 to 78 years
(mean, 59 ± 10 years). There were 37 female (19%) and
156 male (81%) patients. The aneurysm was anterior in 174
(90%) patients, posterior in 18 (9%) patients, and lateral in
1 (0.5%) patient. Significant calcification was present in 23
(12%) patients. Major indications for operation were often
multiple and included angina in 108 (56%) patients, con-
gestive heart failure in 115 (60%) patients, and ventricular
arrhythmias in 86 (45%) patients. Most patients were in
symptom class III (58 [30%]) or IV (102 [53%]) before the
operation. Double- or triple-vessel disease was present in
158 (82%) patients. The distribution of preoperative ejec-
tion fraction (EF) is shown in Fig 1. One hundred eighty-
four (95%) patients had an EF of less than 40% (mean EF,
25% ± 8%). Significant MR was present in 86 (45%)
patients: 2+ in 60 (31%) patients; 3+ in 19 (10%) patients;
and 4+ in 7 (4%) patients.
Since 1988, detailed wall-motion analysis of the ventricu-
logram was possible in 87 patients by using a center-line
method.5 Aneurysms were classified as dyskinetic if absolute
motion of contiguous chords was less than 1 and akinetic if
equal to 1 by this method. Of patients analyzed, 37 (43%) had
dyskinesia, and 50 (57%) had akinesia. The extent of non-
contracting muscle or asynergy was calculated as the per-
centage length of the LV perimeter showing a fractional
shortening below 2 SDs from normal mean values.5 The
mean asynergy was 58 ± 16 for akinetic and 60 ± 12 for dys-
kinetic aneurysms.
Unfortunately, in these patients biplane angiograms were
not always done in referring institutions to allow accurate cal-
culation of ventricular volumes. Of 174 patients with anteri-
or aneurysms, assessment of ventricular size was possible in
128 patients on the basis of echocardiographic determination
of end-diastolic dimension in 57 patients or analysis of the
ventriculogram in 71 patients. Ventricular volume was gross-
ly enlarged in 80 (63%) of 128 patients (end-diastolic dimen-
sion > 63 mm or end-diastolic volume index > 160 mL/m2).
Operative procedure: Tailored scar excision and modi-
fied linear closure. With the patient supported on normo-
thermic cardiopulmonary bypass, the heart was carefully
examined. In many patients it was not possible, on the basis
of ventriculography or echocardiography, to determine
whether akinesis or dyskinesis corresponds to an area of
hibernating myocardium that will benefit from revasculariza-
tion or to an area of scarred, thinned myocardium that should
be resected. Viability studies have been used to try to deter-
mine which patients will most benefit from revasculariza-
tion,8,9 but in our opinion, the decision of whether to revas-
cularize or to excise a portion of nonfunctioning wall is best
made at the time of the operation. In either case, surgical
treatment has something to offer.
If the area of previous infarction consists of a mixture of
viable muscle and scar and there is doubt about the extent of
thinning, we avoid insertion of a ventricular vent, which may
disrupt and embolize intraventricular clot. In such cases we
recommend aspiration with an 18-gauge needle to assess wall
thickness. Once significant thinning of the area has been con-
firmed, a small incision is made. Any clot present is careful-
ly removed. With the unloaded heart open and beating, the
surrounding wall is palpated, and its ability to contract
(regional wall thickening) can be reliably assessed. All
thinned, nonfunctioning portions of the wall are considered
for resection.
The size and shape of the LV cavity is evaluated. Excision
is planned to remove as much nonfunctioning wall as possi-
ble while restoring ventricular size and shape toward normal
conditions by using the modified linear closure, as previous-
ly described.7 In many cases the excised specimen is com-
posed of a mixture of infarcted and viable muscle, and repair
sutures are often placed through relatively thick areas of
myocardium. Sutures are placed further apart on the tissue
edges than on the felt strips so that the length of the incision
is plicated in the closure. This helps to restore the shape of the
ventricle toward normal conditions.
In most patients with an anterior aneurysm, scarring of the
septum is observed. However, only in cases in which a major
portion of the septum is not only scarred but also thinned and
aneurysmal is a septoplasty performed, as previously
described.10 The anterior edge of the patch is incorporated
into the ventricular closure. Once ventricular repair has been
completed, bypass grafting is carried out when indicated,
including a graft to the proximal left anterior descending
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artery whenever possible. To perform grafting, we applied a
crossclamp. Retrograde cardioplegia is used for protection of
the left ventricle, and antegrade cardioplegia or infusion
down a right graft is used to protect the right ventricle. In
patients with ventricular arrhythmias, map-directed ablation
or visually directed septal endocardial excision and cryoabla-
tion at the periphery have been carried out, as previously
described.11
Follow-up. Follow-up was completed in 1998 by means of
telephone contact with patients and referring physician or
office visits when indicated. Preoperative and postoperative
MUGA scans were done in 171 (89%) patients, with LVEF
calculated by means of computerized analysis. Doppler
echocardiograms were done in 170 (88%) patients to assess
MR. In 123 (64%) patients both preoperative and postopera-
tive studies were performed.
Statistical analysis. The SAS (SAS Institute, Inc, Cary
NC) and BMDP (BMDP Software, Los Angeles, Calif) pro-
grams were used for statistical analysis. Patient characteris-
tics were compared by means of the t test for continuous vari-
ables and the χ2 or Fisher exact test for categoric variables.
Results are presented as mean ± SD in the text and tables and
mean ± SE in the figures. Actuarial survival was calculated
by the Kaplan-Meier statistic. A Wilcoxon test was used to
evaluate differences in survival among subgroups of patients.
A good long-term result, defined as 5-year survival without
the need for transplantation or repeated hospitalizations for
congestive heart failure, was evaluated multivariately by a
Cox proportional hazards model with the following building
strategy. Variables with a univariate P value of less than .25
or those of known biologic importance but failing to meet the
critical α level were submitted for consideration to the multi-
variate analysis by using stepwise selection.
Results
At the operation, associated cardiac procedures
included clot removal (n = 55 [29%]), patch septoplas-
ty (n = 24 [12%]), arrhythmia ablation (n = 77 [40%]),
and CABG (n = 175 [91%]; average, 2.9 ± 1.0 grafts
per patient). In 15 (7.8%) patients the entire procedure
was carried out on the beating heart. In the remaining
178 patients, the average crossclamp time was only 60
± 24 minutes. The average pump time was 174 ± 56
minutes. All patients were successfully weaned from
bypass, but 108 (56%) patients required inotrope sup-
port, and 34 (18%) patients required an intra-aortic bal-
loon pump.
There were 5 hospital deaths (mortality, 2.6%). Two
deaths were related to adult respiratory distress syn-
drome in patients receiving amiodarone.12 Three others
were related to congestive heart failure and ventricular
arrhythmias. Three (1.6%) patients had perioperative
myocardial infarctions. Four (2.1%) patients were
reoperated on for bleeding. There were 2 (1.0%) ster-
nal infections, 2 (1.0%) transient ischemic attacks, and
1 (0.5%) stroke.
During follow-up, which extended to 14 years (mean
51 ± 44 months), there were 31 late deaths. Cause of
death was congestive heart failure with or without MR
in 19 patients, sudden death in 2 patients, death caused
by ventricular arrhythmia in 2 patients, stroke in 1
patient, and cancer in 2 patients. Two patients died after
a subsequent transplant, and 1 patient underwent mitral
valve replacement and died postoperatively. The caus-
es of 2 deaths were unknown.
The actuarial survival curve (including hospital
deaths) is shown in Fig 2. Survival was 91% at 1 year,
89% at 2 years, 84% at 5 years, and 66% at 10 years.
Among survivors, 5 patients required cardiac trans-
plantation (mean interval, 36 ± 32 months). Five
patients required pacemaker insertion for bradyarrhyth-
mias, and 1 patient required an automatic implantable
cardioverter defibrillator. According to multivariable
analysis (Table I), predictors of poor 5-year result
included preoperative echocardiographic evidence of
MR of 2+ or greater, symptoms of congestive heart
failure, and ventricular tachycardia (VT). In our select-
ed patients poor outcome was not related to age, sex,
extent of coronary artery disease, EF, crossclamp time,
or pump time. Because assessment of wall motion and
ventricular volume was not available in all patients, we
could not enter these variables into the model.
However, 17 (21%) of 80 patients with grossly
enlarged hearts had poor results at 5 years versus 4
(8%) of 48 patients with small hearts (P = .040). Of 37
patients with dyskinesis, 3 (9%) had a bad 5-year result
versus 6 (12%) of 50 of those with akinesis (P = .556).
Among survivors, 123 (78%) of 157 were symp-
tomatically improved, with 64 (41%) in symptom class
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Fig 1. Histogram showing distribution of preoperative LVEF
among our patient population.
I and 62 (39%) in symptom class II. Fig 3 shows the
change in symptom class for survivors (average
increase, 1.4 ± 1.0). MUGA assessment preoperatively
and postoperatively was available in 98 of the patients
with an anterior aneurysm. There was a statistically sig-
nificant increase in EF (determined by the paired t test),
with a mean change of 8.9% ± 9.6% (P < .001).
Preoperative and postoperative echocardiograms were
performed in 123 (64%) of 193 patients. Of these, 70
patients had 2+ or more MR preoperatively. In 40
(57%) of these patients, the MR was improved by at
least 1 grade postoperatively (Fig 4).
Discussion
This article presents short- and long-term results
achieved in a large series with aneurysm repair by
means of a modified linear closure technique. The
series includes patients with akinetic and dyskinetic
aneurysms both large and small. We have outlined the
selection criteria used in choosing patients for operative
intervention. With this approach, we have achieved
excellent surgical results, hospital mortality of only
2.6%, and 5-year survival of 84%. Multivariate predic-
tors of poor outcome at 5 years were preoperative MR
of 2+ or greater, congestive heart failure, and VT. In
patients with volume data, marked ventricular enlarge-
ment also predicted a poor outcome.
In prior reports, operative mortality has been
increased in patients with akinetic versus dyskinetic
aneurysms.6,13,14 Furthermore, it has been suggested
that only patients with clear-cut dyskinesis will benefit
from aneurysm excision in terms of symptom relief,
improved EF, and long-term survival.6,14 In our series
87 patients had detailed wall-motion analysis, which
allowed their classification as akinetic or dyskinetic
(appendix). There was no difference between the 2
groups with respect to basic patient characteristics. Two
patients in the akinetic group died in the hospital, with
no deaths in the dyskinetic group. Akinetic patients
were more likely to need inotropic or intra-aortic bal-
loon pump support postoperatively, but these differ-
ences did not reach statistical significance. Among sur-
vivors, the postoperative change in EF was greater in
the dyskinetic group (10.9% ± 9.9% vs 5.7% ± 10%), a
difference that was almost statistically significant (P =
.08). Nevertheless, patients in both groups experienced
678 Mickleborough, Carson, Ivanov The Journal of Thoracic and
Cardiovascular Surgery
April 2001
Fig 2.  Actuarial survival after LV aneurysm resection. Figures in parentheses at the top indicate number of patients
left at risk at that time of follow-up
Table I. Multivariable predictors of poor 5-year result by means of Cox regression analysis in patients undergoing
repair of an LV aneurysm
Variable Risk ratio 95% CI χ2 P value
Echocardiographic MR ≥2+ 2.94 1.3-6.6 12.6 .0004
Congestive heart failure 3.76 1.3-11 8.6 .0034
VT 2.34 1.1-5.0 3.7 .0539
CI, Confidence interval.
similar improvement in symptoms postoperatively, and
5-year survival was similar (91% dyskinetic versus 94%
akinetic). Our findings are in agreement with those
reported by Dor and colleagues,5 who also showed no
difference in preoperative variables, operating room
mortality, improvement in symptoms, or long-term sur-
vival between the akinetic and dyskinetic groups.
An important aspect of our approach, especially in aki-
netic aneurysms, is assessment of wall thickness and
function in the open-beating ventricle, which allows us to
make decisions about resection versus revascularization
without relying on viability studies.15 We agree with
Suma and colleagues16 that in akinetic aneurysms the
limits of scarring are not always well demarcated nor is
the extent of endocardial scar a reliable indicator of the
border between functioning and nonfunctioning wall. In
these cases, palpation and assessment of regional wall
motion in the unloaded beating heart are important to
guide the extent of resection and repair. Furthermore, we
believe, as does Jatene,2 that carrying out the repair on the
beating heart has the advantages of minimizing ischemic
time (crossclamp time, 60 ± 24 minutes) and facilitating
decision making with regard to the need for a septal patch
and optimal restoration of LV geometry. By resecting
nonfunctioning wall, excluding aneurysmal portions of
the septum, and plicating the length of the incision in the
repair, we are attempting to decrease chamber dimen-
sions, wall tension, and wall stress and to restore LV
geometry toward normal.
In our cases we have tailored scar excision to leave
the left anterior descending artery for revascularization
whenever possible, even if the distal vessel has been
included in the repair. We believe that revascularization
of even a small portion of the septum may be important
in improving short- and long-term results.17,18
Our series includes a high proportion of patients
with multivessel coronary disease, advanced LV dys-
function, and ventricular arrhythmias, factors that
have been found in other series to be related to
increased operative mortality.17,19-21 Nevertheless,
our hospital mortality was low (2.6%) compared with
that in other recently reported aneurysm series,
which range from 3% to 18%.17,22-24 Clearly, case
selection and operative technique may account for
these differences.
In this series there were few perioperative complica-
tions. Only 18% of patients required intra-aortic bal-
loon pump support versus 26% to 65% in other report-
ed series.14,23 Few patients required reoperation for
bleeding or sternal wound complications. There was
only one stroke in this series. Like Elefteriades and col-
leagues,23 we believe that removal of endocardial
thrombus before insertion of an LV vent has con-
tributed to this low perioperative stroke rate.
In this series objective evidence of improved LV
function after operation was provided by MUGA data.
Our average increase in EF is similar to that reported in
other series (10%-14%).25-27
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Fig 3.  Preoperative and postoperative symptom class. Fig 4. Results of preoperative and postoperative echocardio-
graphic assessment of MR. MR has been graded on a scale of
1+ to 4+.
In considering patients for possible aneurysm repair,
the issue of concomitant mitral insufficiency is an
important one. During the time frame of this series, we
were reluctant to undertake mitral valve replacement or
repair in addition to revascularization and LV recon-
struction. If severe MR was obvious, we tended to con-
sider the patient’s condition inoperable. However, pre-
operative Doppler echocardiography often indicated
MR of 2+ when none was suspected on the angiogram,
and 26 patients included in this series had MR of 3+ to
4+. We went ahead with the operations in these select-
ed cases because the severe MR was of relatively recent
onset, with no evidence of recent myocardial infarction
or chordal rupture. In these cases we believed that
resection of the aneurysm would improve mitral func-
tion, which it did in 21 (81%) of 26. Possible mecha-
nisms for this improvement include (1) decreased
dilatation of the anulus caused by decreased ventricular
size, (2) improved function of ischemic papillary mus-
cles related to revascularization, or (3) realignment of
papillary muscles related to improved geometry after
ventricular repair. Of patients with a preoperative MR
of 3+ to 4+, all but 2 are doing well at an average of 5.8
± 2.5 years postoperatively. In our multivariate analy-
sis, however, the presence of MR of 2+ or greater was
found to be predictive of a poor 5-year result.
Recently, Bolling and colleagues28 have recommended
mitral valvoplasty in patients with MR and decreased
ventricular function. We are now using intraoperative
transesophageal echocardiography to evaluate residual
MR after completion of the ventricular repair. Whether
the addition of an annuloplasty ring would further
improve long-term results needs to be assessed.
After aneurysm resection, close follow-up and care-
ful adjustment of medications is necessary to optimize
symptomatic improvement. During follow-up, 8
patients were referred for additional procedures
because of increasing congestive heart failure (7 trans-
plants and 1 mitral valve replacement). Nevertheless,
our 5-year survival was 84%, which can be compared
with survival in other reported series at 2 years (86%)25
and at 5 years (58%-70%).17,27
Pasini and colleagues17 reported an 8.6% incidence
of sudden deaths after aneurysm repair. We used an
aggressive approach in patients with ventricular
arrhythmias, which includes map-directed or visually
directed VT ablation, as previously described.11 In this
series, during follow-up, there were 2 sudden deaths, 2
deaths related to ventricular arrhythmias, and 2 deaths
of unknown cause. If we include the deaths of unknown
cause, the mortality related to possible sudden death
was only 3.1% (6/193). We believe that our vigorous
approach to patients with ventricular arrhythmias
explains this low incidence of sudden death.
Nevertheless, preoperative VT was a predictor of poor
outcome at 5 years. VT tends to occur in dilated hearts
(45/80 [56%] vs 13/48 [27%], P = .001). We suggest
that ventricular arrhythmias are a marker of more
severe ventricular remodeling and a less favorable 5-
year prognosis.
In recent years, the number of patients referred for
aneurysm resection has decreased in all but a few cen-
ters.22 This may be due in part to successful treatment
of acute infarction with thrombolysis5 and preservation
of epicardial muscle, which may prevent dyskinetic
scar formation. After infarction, advances in medical
treatment have proven effective in controlling symp-
toms of heart failure, and patients live longer before
gross myocardial decompensation occurs. It is our
experience, however, that once decompensation begins,
deterioration may be rapid, and patients may die before
appropriate investigation can be done and the possibil-
ity of surgical treatment entertained.
We agree with Dor and colleagues5,22 that akinesia
and dyskinesia are part of the same process. Like Dor
and colleagues, we recommend early repair because
surgical risk in selected patients is low. If repair is
delayed, contractile function of remote muscle may
deteriorate with a progressive decrease in EF and
dilatation of the heart.29,30 We have shown that gross
dilatation and mitral insufficiency are predictors of a
poor 5-year surgical result. We suggest that patients in
whom aneurysms develop after infarction should be
followed closely and considered for surgical treatment
when signs of decompensation first occur, such as
increasing symptoms with optimal medical manage-
ment, or in asymptomatic patients if there is evidence
of increasing ventricular volume or MR. Operations
should be considered before these patients reach the
stage when transplantation is the only reasonable
option.
This series demonstrates that in selected patients
resection of an akinetic or dyskinetic aneurysm and
repair with a modified linear closure technique plus
septoplasty when indicated can be done in the beating
heart with a low operative mortality and provides good
symptomatic improvement and excellent 5-year sur-
vival. The exact role of concomitant mitral annuloplas-
ty in patients with an aneurysm and mitral insufficien-
cy requires further investigation.
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Appendix. Classification of patients as akinetic or dyskinetic
Akinetic Dyskinetic P value
Age (y) 60 ± 10 59 ± 9 .693
Male sex 37/50 (74%) 32/37 (87%) .155
Anterior location 42/50 (84%) 34/37 (92%) .274
Angina 24/50 (48%) 18/37 (49%) .952
Congestive heart failure 28/50 (56%) 22/37 (60%) .747
VT 19/50 (38%) 19/37 (51%) .263
Symptom class
I 2/50 (4%) 3/37 (8%) .235
II 7/50 (14%) 6/37 (16%)
III 21/50 (42%) 8/37 (22%)
IV 20/50 (40%) 20/37 (54%)
Extent of coronary artery disease
Single 8/50 (16%) 8/37 (22%) .791
Double 21/50 (42%) 14/37 (38%)
Triple 21/50 (42%) 15/37 (41%)
EF
>40% 1/50 (2%) 3/37 (8%) .188
20%-40% 21/50 (42%) 10/37 (27%)
<20% 28/50 (56%) 24/37 (65%)
MR 2+ or more 28/45 (62%) 21/34 (62%) .967
Asynergy (%) 58 ± 16 61 ± 12 .335
Crossclamp time (min) 58 ± 24 59 ± 27 .909
Pump time (min) 158 ± 44 174 ± 53 .137
Patients grafted (%) 47/50 (94%) 33/37 (89%) .415
Average No. of grafts 3.0 ± 1.1 2.8 ± 1.1 .667
Use of LITA 26/50 (52%) 14/37 (38%) .190
Patch septoplasty 6/50 (12%) 9/37 (24%) .132
IABP 13/50 (26%) 6/37 (16%) .275
Inotropeic agents 30/50 (60%) 17/37 (46%) .193
Hospital mortality 2/50 (4%) 0/37 (0%) .218
Improved symptoms 38/48 (79%) 25/33 (76%) .717
Preoperative symptom class 3.2 ± 0.8 3.2 ± 1.0 .854
Postoperative symptom class 1.7 ± 0.9 1.8 ± 0.9 .494
LVEDP 23.3 ± 8.7 21.8 ± 5.9 .497
Change in EF 5.7 ± 10.2 10.9 ± 9.9 .080
LITA, Left internal thoracic artery; IABP, intra-aortic balloon pump; LVEDP, left ventricular end-diastolic pressure.
